Biblio
Characterization of CAR T Cells Manufactured Using Genetically Engineered Artificial Antigen Presenting Cells. Cell J. 2023;25(10):674-687.
. The combination effect of Prominin1 (CD133) suppression and Oxaliplatin treatment in colorectal cancer therapy. Biomed Pharmacother. 2021;137:111364.
Combination of B7H6-siRNA and temozolomide synergistically reduces stemness and migration properties of glioblastoma cancer cells. Exp Cell Res. 2023:113667.
. Corrigendum to "STA-21, a small molecule STAT3 inhibitor, ameliorates experimental autoimmune encephalomyelitis by altering Th-17/Treg balance" [Int. Immunopharmacol. 119 (2023) 110160]. Int Immunopharmacol. 2023:110303.
Dendritic cell vaccination strategy for the treatment of acute myeloid leukemia: a systematic review. Cytotherapy. 2024.
. Development of an injectable chitosan-based hydrogel containing nano-hydroxy-apatite and alendronate for MSC-based therapy. Int J Biol Macromol. 2024:129737.
. Enhanced intracellular accumulation and cytotoxicity of bortezomib against liver cancer cells using N-stearyl lactobionamide surface modified solid lipid nanoparticles. Int J Pharm. 2023:123635.
. Enrichment of undifferentiated type a spermatogonia from goat testis using discontinuous percoll density gradient and differential plating. Avicenna J Med Biotechnol. 2014;6(2):94-103.
Generation and Characterization of Anti-CD34 Monoclonal Antibodies that React with Hematopoietic Stem Cells. Cell J. 2014;16(3):361-6.
. Immunomodulatory Nature and Site Specific Affinity of Mesenchymal Stem Cells: a Hope in Cell Therapy. Adv Pharm Bull. 2014;4(1):5-13.
. Large Scale Generation and Characterization of Anti-Human CD34 Monoclonal Antibody in Ascetic Fluid of Balb/c Mice. Adv Pharm Bull. 2013;3(1):211-216.
. Mass-Production and Characterization of Anti-CD20 Monoclonal Antibody in Peritoneum of Balb/c Mice. Adv Pharm Bull. 2013;3(1):109-113.
. MicroRNA-143 as a potential tumor suppressor in cancer: An insight into molecular targets and signaling pathways. Pathol Res Pract. 2023;250:154792.
. MicroRNA-143-5p Suppresses ER-Positive Breast Cancer Development by Targeting Oncogenic HMGA2. Clin Breast Cancer. 2023.
. Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials. Int J Biol Macromol. 2020.
. The role of CD44 in cancer chemoresistance: a concise review. Eur J Pharmacol. 2021:174147.
. Role of Nrf2 and mitochondria in cancer stem cells; in carcinogenesis, tumor progression, and chemoresistance. Biochimie. 2020.
. Signaling pathways and microRNAs, the orchestrators of NANOG activity during cancer induction. Life Sci. 2020:118337.
. Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression. Eur J Pharmacol. 2020:173235.
Silencing of IL-6 and STAT3 by siRNA loaded hyaluronate-N,N,N-trimethyl chitosan nanoparticles potently reduces cancer cell progression. Int J Biol Macromol. 2020.
Silencing of p68 and STAT3 synergistically diminishes cancer progression. Life Sci. 2020:117499.
Stem cell membrane, stem cell-derived exosomes and hybrid stem cell camouflaged nanoparticles: A promising biomimetic nanoplatforms for cancer theranostics. J Control Release. 2022.
. Strategies for modifying the chimeric antigen receptor (CAR) to improve safety and reduce toxicity in CAR T cell therapy for cancer. Int Immunopharmacol. 2023;125(Pt A):111093.
. Targeted delivery of doxorubicin by Thermo/pH-responsive magnetic nanoparticles in a rat model of breast cancer. Toxicol Appl Pharmacol. 2022:116036.
.